Trafficking and differentiation of mesenchymal stem cells

Journal of Cellular Biochemistry

Volumn 106, Issue 6, 2009, Pages 984-991

  Liu, Zhao Jun ^a,b   Zhuge, Ying ^a   Velazquez, Omaida C ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

Author keywords

Cell differentiation; Cell traffick; Mesenchymal stem cells

Indexed keywords

BONE MORPHOGENETIC PROTEIN; CHEMOKINE RECEPTOR CXCR4; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; HERMES ANTIGEN; INTEGRIN; PADGEM PROTEIN; PLATELET DERIVED GROWTH FACTOR B; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; SOMATOMEDIN; STROMAL CELL DERIVED FACTOR 1ALPHA; TRANSCRIPTION FACTOR SOX9; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ARTICLE; BINDING AFFINITY; CELL DIFFERENTIATION; CELL HOMING; CELL LINEAGE; CELL MIGRATION; CELL SURVIVAL; HOMEOSTASIS; HUMAN; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MESODERM; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; REGENERATIVE MEDICINE; SIGNAL TRANSDUCTION; STEM CELL MOBILIZATION; TISSUE DISTRIBUTION; TISSUE ENGINEERING; TISSUE REGENERATION;

ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL LINEAGE; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MESODERM; SIGNAL TRANSDUCTION;

EID: 66149114386     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22091     Document Type: Article

References (71)

1. Abbott JD, Huang Y, Liu D, Hickey R, Krause DS, Giordano FJ. 2004. Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 110:3300-3305.
2. Baksh D, Tuan RS. 2007. Canonical and non-canonical Wnts differentially affect the development potential of primary isolate of human bone marrow mesenchymal stem cells. J Cell Physiol 212:817-826.
3. Barry F, Boynton RE, Liu B, Murphy JM. 2001. Chondrogenic differentiation of mesenchymal stem cells from bone marrow: Differentiation-dependent gene expression of matrix components. Exp Cell Res 268:189-200.
4. Belema-Bedada F, Uchida S, Martire A, Kostin S, Braun T. 2008. Efficient homing of multipotent adult mesenchymal stem cells depends on FROUNT-mediated clustering of CCR2. Cell Stem Cell 2:566-575.
5. Bianco P, Riminucci M, Gronthos S, Robey PG. 2001. Bone marrow stromal stem cells: Nature, biology, and potential applications. Stem Cells 19:180-192.
6. Bianco P, Robey PG, Simmons PJ. 2008. Mesenchymal stem cells: Revisiting history, concepts, and assays. Cell Stem Cell 2:313-319.
7. Billon N, Iannarelli P, Monteiro MC, Glavieux-Pardanaud C, Richardson WD, Kessaris N, Dani C, Dupin E. 2007. The generation of adipocytes by the neural crest. Development 134:2283-2292.
8. Caplan AI. 1994. The mesengenic process. Clin Plast Surg 21:429-435.
9. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME, Capla JM, Galiano RD, Levine JP, Gurtner GC. 2004. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 10:858-864.
10. Chavakis E, Hain A, Vinci M, Carmona G, Bianchi ME, Vajkoczy P, Zeiher AM, Chavakis T, Dimmeler S. 2007. High-mobility group box 1 activates integrin-dependent homing of endothelial progenitor cells. Circ Res 100:204-212.
11. Chen LB, Jiang XB, Yang L. 2004. Differentiation of rat marrow mesenchymal stem cells into pancreatic islet beta-cells. World J Gastroenterol 10:3016-3020.
12. Chen FH, Rousche KT, Tuan RS. 2006. Technology Insight: Adult stem cells in cartilage regeneration and tissue engineering. Nat Clin Pract Rheumatol 2:373-382.
13. Covas DT, Panepucci RA, Fontes AM, Silva WA, Jr., Orellana MD, Freitas MC, Neder L, Santos AR, Peres LC, Jamur MC, Zago MA. 2008. Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with CD146+ perivascular cells and fibroblasts. Exp Hematol 36:642-654.
14. Crisan M, Yap S, Casteilla L, Chen CW, Corselli M, Park TS, Andriolo G, Sun B, Zheng B, Zhang L, Norotte C, Teng PN, Traas J, Schugar R, Deasy BM, Badylak S, Buhring HJ, Giacobino JP, Lazzari L, Huard J, Peault B. 2008. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3:301-313.
15. D'Ippolito G, Diabira S, Howard GA, Menei P, Roos BA, Schiller PC. 2004. Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential. J Cell Sci 117:2971-2981.
16. Djouad F, Delorme B, Maurice M, Bony C, Apparailly F, Louis-Plence P, Canovas F, Charbord P, Noel D, Jorgensen C. 2007. Microenvironmental changes during differentiation of mesenchymal stem cells towards chondrocytes. Arthritis Res Ther 9:R33.
17. Doherty MJ, Ashton BA, Walsh S, Beresford JN, Grant ME, Canfield AE. 1998. Vascular pericytes express osteogenic potential in vitro and in vivo. J Bone Miner Res 13:828-838.
18. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E. 2006. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317.
19. Farrington-Rock C, Crofts NJ, Doherty MJ, Ashton BA, Griffin-Jones C, Canfield AE. 2004. Chondrogenic and adipogenic potential of microvascular pericytes. Circulation 110:2226-2232.
20. Filshie RJ, Zannettino AC, Makrynikola V, Gronthos S, Henniker AJ, Bendall LJ, Gottlieb DJ, Simmons PJ, Bradstock KF. 1998. MUC18, a member of the immunoglobulin superfamily, is expressed on bone marrow fibroblasts and a subset of hematological malignancies. Leukemia 12:414-421.
21. Friedenstein AJ, Piatetzky S II, Petrakova KV. 1966. Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol 16:381-390.
22. Gallagher KA, Liu ZJ, Xiao M, Chen H, Goldstein LJ, Buerk DG, Nedeau A, Thom SR, Velazquez OC. 2007. Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha. J Clin Invest 117:1249-1259.
23. Gronthos S, Zannettino AC, Hay SJ, Shi S, Graves SE, Kortesidis A, Simmons PJ. 2003. Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. J Cell Sci 116:1827-1835.
24. Gu Y, Filippi MD, Cancelas JA, Siefring JE, Williams EP, Jasti AC, Harris CE, Lee AW, Prabhakar R, Atkinson SJ, Kwiatkowski DJ, Williams DA. 2003. Hematopoietic cell regulation by Rac1 and Rac2 guanosine triphosphatases. Science 302:445-449.
25. Haider H, Jiang S, Idris NM, Ashraf M. 2008. IGF-1-overexpressing mesenchymal stem cells accelerate bone marrow stem cell mobilization via paracrine activation of SDF-1{alpha}/CXCR4 signaling to promote myocardial repair. Circ Res 103:1300-1308.
26. Hennig T, Lorenz H, Thiel A, Goetzke K, Dickhut A, Geiger F, Richter W. 2007. Reduced chondrogenic potential of adipose tissue derived stromal cells correlates with an altered TGFbeta receptor and BMP profile and is overcome by BMP-6. J Cell Physiol 211:682-691.
27. Hofstetter CP, Schwarz EJ, Hess D, Widenfalk J, El Manira A, Prockop DJ, Olson L. 2002. Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc Natl Acad Sci USA 99:2199-2204.
28. Ito T, Sawada R, Fujiwara Y, Tsuchiya T. 2008. FGF-2 increases osteogenic and chondrogenic differentiation potentials of human mesenchymal stem cells by inactivation of TGF-beta signaling. Cytotechnology 56:1-7.
29. Jaganathan BG, Ruester B, Dressel L, Stein S, Grez M, Seifried E, Henschler R. 2007. Rho inhibition induces migration of mesenchymal stromal cells. Stem Cells 25:1966-1974.
30. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund T, Blackstad M, Du J, Aldrich S, Lisberg A, Low WC, Largaespada DA, Verfaillie CM. 2002. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418:41-49.
31. Kahn CR. 2008. Medicine. Can we nip obesity in its vascular bud? Science 322:542-543.
32. Katoh S, Zheng Z, Oritani K, Shimozato T, Kincade PW. 1995. Glycosylation of CD44 negatively regulates its recognition of hyaluronan. J Exp Med 182:419-429.
33. Kohyama J, Abe H, Shimazaki T, Koizumi A, Nakashima K, Gojo S, Taga T, Okano H, Hata J, Umezawa A. 2001. Brain from bone: Efficient "meta-differentiation" of marrow stroma-derived mature osteoblasts to neurons with Noggin or a demethylating agent. Differentiation 68:235-244.
34. Krampera M, Pizzolo G, Aprili G, Franchini M. 2006. Mesenchymal stem cells for bone, cartilage, tendon and skeletal muscle repair. Bone 39:678-683.
35. Kratchmarova I, Blagoev B, Haack-Sorensen M, Kassem M, Mann M. 2005. Mechanism of divergent growth factor effects in mesenchymal stem cell differentiation. Science 308:1472-1477.
36. Lazarus HM, Haynesworth SE, Gerson SL, Rosenthal NS, Caplan AI. 1995. Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells); implications for therapeutic use. Bone Marrow Transplant 16:557-564.
37. Ley K, Laudanna C, Cybulsky MI, Nourshargh S. 2007. Getting to the site of inflammation: The leukocyte adhesion cascade updated. Nat Rev Immunol 7:678-689.
38. Lin G, Garcia M, Ning H, Banie L, Gio YL, Lue TF, Lin CS. 2008. Defining stem and progenitor cells within adipose tissue. Stem Cells Dev 17:1053-1063.
39. Liu ZJ, Velazquez OC. 2008. Hyperoxia, endothelial progenitor cell mobilization, and diabetic wound healing. Antioxid Redox Signal 10:1869-1882.
40. Liu JW, Dunoyer-Geindre S, Serre-Beinier V, Mai G, Lambert JF, Fish RJ, Pernod G, Buehler L, Bounameaux H, Kruithof EK. 2007. Characterization of endothelial-like cells derived from human mesenchymal stem cells. J Thromb Haemost 5:826-834.
41. Luster AD, Alon R, von Andrian UH. 2005. Immune cell migration in inflammation: Present and future therapeutic targets. Nat Immunol 6:1182-1190.
42. Mareschi K, Novara M, Rustichelli D, Ferrero I, Guido D, Carbone E, Medico E, Madon E, Vercelli A, Fagioli F. 2006. Neural differentiation of human mesenchymal stem cells: Evidence for expression of neural markers and eag K+ channel types. Exp Hematol 34:1563-1572.
43. Marinova-Mutafchieva L, Taylor P, Funa K, Maini RN, Zvaifler NJ. 2000. Mesenchymal cells expressing bone morphogenetic protein receptors are present in the rheumatoid arthritis joint. Arthritis Rheum 43:2046-2055.
44. Matsuda C, Takagi M, Hattori T, Wakitani S, Yoshida T. 2005. Differentiation of human bone marrow mesenchymal stem cells to chondrocytes for construction of three-dimensional cartilage tissue. Cytotechnology 47:11-17.
45. Mimeault M, Batra SK. 2008. Recent progress on normal and malignant pancreatic stem/progenitor cell research: Therapeutic implications for the treatment of type 1 or 2 diabetes mellitus and aggressive pancreatic cancer. Gut 57:1456-1468.
46. Minguell JJ, Erices A, Conget P. 2001. Mesenchymal stem cells. Exp Biol Med (Maywood) 226:507-520.
47. Nedeau AE, Bauer RJ, Gallagher K, Chen H, Liu ZJ, Velazquez OC. 2008. A CXCL5- and bFGF-dependent effect of PDGF-B-activated fibroblasts in promoting trafficking and differentiation of bone marrow-derived mesenchymal stem cells. Exp Cell Res 314:2176-2186.
48. O'Rahilly R, Muller F. 2007. The development of the neural crest in the human. J Anat 211:335-351.
49. Palumbo R, Bianchi ME. 2004. High mobility group box 1 protein, a cue for stem cell recruitment. Biochem Pharmacol 68:1165-1170.
50. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. 1999. Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
51. Prockop DJ. 1997. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276:71-74.
52. Provenzano PP, Inman DR, Eliceiri KW, Trier SM, Keely PJ. 2008. Contact guidance mediated three-dimensional cell migration is regulated by Rho/ROCK-dependent matrix reorganization. Biophys J 95:5374-5384.
53. Ruster B, Gottig S, Ludwig RJ, Bistrian R, Muller S, Seifried E, Gille J, Henschler R. 2006. Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells. Blood 108:3938-3944.
54. Sacchetti B, Funari A, Michienzi S, Di Cesare S, Piersanti S, Saggio I, Tagliafico E, Ferrari S, Robey PG, Riminucci M, Bianco P. 2007. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 131:324-336.
55. Sackstein R, Merzaban JS, Cain DW, Dagia NM, Spencer JA, Lin CP, Wohlgemuth R. 2008. Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone. Nat Med 14:181-187.
56. Sakaguchi Y, Sekiya I, Yagishita K, Muneta T. 2005. Comparison of human stem cells derived from various mesenchymal tissues: Superiority of synovium as a cell source. Arthritis Rheum 52:2521-2529.
57. Schwab KE, Hutchinson P, Gargett CE. 2008. Identification of surface markers for prospective isolation of human endometrial stromal colony-forming cells. Hum Reprod 23:934-943.
58. Sekiya I, Larson BL, Vuoristo JT, Reger RL, Prockop DJ. 2005. Comparison of effect of BMP-2, -4, and -6 on in vitro cartilage formation of human adult stem cells from bone marrow stroma. Cell Tissue Res 320:269-276.
59. Sen M. 2005. Wnt signalling in rheumatoid arthritis. Rheumatology (Oxford) 44:708-713.
60. Shi S, Gronthos S. 2003. Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp. J Bone Miner Res 18:696-704.
61. Sotiropoulou PA, Perez SA, Salagianni M, Baxevanis CN, Papamichail M. 2006. Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. Stem Cells 24:462-471.
62. Tang W, Zeve D, Suh JM, Bosnakovski D, Kyba M, Hammer RE, Tallquist MD, Graff JM. 2008. White fat progenitor cells reside in the adipose vasculature. Science 322:583-586.
63. Tsuchiya H, Kitoh H, Sugiura F, Ishiguro N. 2003. Chondrogenesis enhanced by overexpression of sox9 gene in mouse bone marrow-derived mesenchymal stem cells. Biochem Biophys Res Commun 301:338-343.
64. Tuli R, Tuli S, Nandi S, Huang X, Manner PA, Hozack WJ, Danielson KG, Hall DJ, Tuan RS. 2003. Transforming growth factor-beta-mediated chondrogenesis of human mesenchymal progenitor cells involves N-cadherin and mitogen-activated protein kinase and Wnt signaling cross-talk. J Biol Chem 278:41227-41236.
65. Wakitani S, Saito T, Caplan AI. 1995. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 18:1417-1426.
66. Walter DH, Haendeler J, Reinhold J, Rochwalsky U, Seeger F, Honold J, Hoffmann J, Urbich C, Lehmann R, Arenzana-Seisdesdos F, Aicher A, Heeschen C, Fichtlscherer S, Zeiher AM, Dimmeler S. 2005. Impaired CXCR4 signaling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patients with coronary artery disease. Circ Res 97:1142-1151.
67. Woodbury D, Schwarz EJ, Prockop DJ, Black IB. 2000. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 61:364-370.
68. Zannettino AC, Paton S, Arthur A, Khor F, Itescu S, Gimble JM, Gronthos S. 2008. Multipotential human adipose-derived stromal stem cells exhibit a perivascular phenotype in vitro and in vivo. J Cell Physiol 214:413-421.
69. Zhang D, Fan GC, Zhou X, Zhao T, Pasha Z, Xu M, Zhu Y, Ashraf M, Wang Y. 2008. Over-expression of CXCR4 on mesenchymal stem cells augments myoangiogenesis in the infarcted myocardium. J Mol Cell Cardiol 44:281-292.
70. Zhou S, Eid K, Glowacki J. 2004. Cooperation between TGF-beta and Wnt pathways during chondrocyte and adipocyte differentiation of human marrow stromal cells. J Bone Miner Res 19:463-470.
71. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, Alfonso ZC, Fraser JK, Benhaim P, Hedrick MH. 2002. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13:4279-4295.